This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Masako Soma: Innovator in Antibody-Drug Conjugates
Introduction
Masako Soma is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of antibody-drug conjugates. Her innovative work focuses on enhancing the efficacy of targeted therapies in medicine.
Latest Patents
Masako Soma holds a patent for a "Protein recognizing drug moiety of antibody-drug conjugate." This invention involves a protein that recognizes a drug moiety of an antibody-drug conjugate, which is conjugated to an antibody via a linker. The patent also describes a method for quantifying the concentration of the antibody-drug conjugate in plasma of a mammal after administration, as well as a method for identifying the tissue distribution of the conjugate.
Career Highlights
Masako Soma is currently employed at Daiichi Sankyo Company, Limited, where she continues to advance her research in antibody-drug conjugates. Her work has been instrumental in developing new therapeutic strategies that improve patient outcomes.
Collaborations
Throughout her career, Masako has collaborated with notable colleagues, including Hiroshi Kuga and Takeshi Masuda. These partnerships have fostered innovation and contributed to the success of her projects.
Conclusion
Masako Soma's contributions to the field of biochemistry and her innovative patent on antibody-drug conjugates highlight her role as a leading inventor. Her work continues to pave the way for advancements in targeted therapies, showcasing the importance of innovation in medicine.